COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Open Access
- 22 April 2020
- journal article
- editorial
- Published by Elsevier BV in Immunity
- Vol. 52 (5), 731-733
- https://doi.org/10.1016/j.immuni.2020.04.003
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Pleiotropy and Specificity: Insights from the Interleukin 6 Family of CytokinesImmunity, 2019
- Understanding Angiotensin II Type 1 Receptor Signaling in Vascular PathophysiologyHypertension, 2018
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicitiesNature Reviews Clinical Oncology, 2017
- SARS and MERS: recent insights into emerging coronavirusesNature Reviews Microbiology, 2016
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Angiotensin-converting enzyme 2 protects from severe acute lung failureNature, 2005
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003